Carbiotix AB carries a market capitalization of 32.74M, placing it among publicly traded companies globally. Its enterprise value stands at 21.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 32.74M |
| Enterprise Value | 21.53M |
Carbiotix AB currently has 4.98M shares outstanding.
| Shares Outstanding | 4.98M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 24.99, and the price-to-book ratio stands at -0.24.
| PE Ratio | N/A |
| PS Ratio | 24.99 |
| PB Ratio | -0.24 |
| P/TBV Ratio | 25.67 |
| P/FCF Ratio | -1.84 |
| P/OCF Ratio | -1.59 |
| EV / Sales | 24.31 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Carbiotix AB maintains a current ratio of 1.19, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.19 |
| Quick Ratio | 0.30 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -19,352.93 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -54.77 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Carbiotix AB's stock has declined approximately -41.76991% over the past 52 weeks. The 50-day moving average sits at 6.38, while the 200-day moving average is 8.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.76991% |
| 50-Day Moving Average | 6.38 |
| 200-Day Moving Average | 8.87 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Carbiotix AB generated 885,585.00 in revenue and converted that into -14.46M in net income, yielding earnings per share of -3.29. EBITDA reached -14.03M, while operating income came in at -14.03M.
| Revenue | 885,585.00 |
| Gross Profit | 2.62M |
| Operating Income | -14.03M |
| Pretax Income | -14.46M |
| Net Income | -14.46M |
| EBITDA | -14.03M |
| EBIT | -14.03M |
| Earnings Per Share (EPS) | -3.29 |
Total book value stands at -91.95M, with working capital of 388,558.00 providing operational flexibility.
| Cash & Cash Equivalents | 605,294.00 |
| Total Debt | N/A |
| Net Debt | -605,294.00 |
| Equity (Book Value) | -91.95M |
| Book Value Per Share | -20.94 |
| Working Capital | 388,558.00 |
Carbiotix AB produced -13.95M in operating cash flow over the past twelve months. After subtracting -1.94M in capital expenditures, free cash flow totaled -15.89M - equivalent to -3.62 per share.
| Operating Cash Flow | -13.95M |
| Capital Expenditures | -1.94M |
| Free Cash Flow | -15.89M |
| FCF Per Share | -3.62 |
Carbiotix AB operates with a gross margin of 296.12, reflecting its pricing power and cost economics. The operating margin of -1,584.36 and net profit margin of -1,632.30 provide insight into operational efficiency.
| Gross Margin | 296.12 |
| Operating Margin | -1,584.36 |
| Pretax Margin | -1,632.30 |
| Profit Margin | -1,632.30 |
| EBITDA Margin | -1,584.36 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -51.72 |
| FCF Yield | -54.28 |
Carbiotix AB's most recent stock split took place on September 17, 2024 with a 100:1 split ratio.
| Last Split Date | 9/17/2024 |
| Split Ratio | 100:1 |
Carbiotix AB posts an Altman Z-Score of -56.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -56.04 |